HIPAA Privacy Clause Samples

HIPAA Privacy. Gallagher and the Client will each comply with any prohibitions, restrictions, limitations, conditions, or other requirements to the extent they apply to them directly or indirectly pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and its implementing regulation concerning privacy of individually identifiable health information as set forth in 45 CFR Parts 160-164, as amended from time to time. When required, the Client, as a representative of the health plans and Gallagher will enter into a separate Business Associate Agreement.

HIPAA Privacy. ▇▇▇▇▇▇▇▇▇ and Client will each comply with any prohibitions, restrictions, limitations, conditions, or other requirements to the extent they apply to them directly or indirectly pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and its implementing regulation concerning privacy of individually identifiable health information as set forth in 45 CFR Parts 160-164, as amended from time to time. When required, Client, as a representative of the health plans, and ▇▇▇▇▇▇▇▇▇ will enter into a separate Business Associate Agreement.

HIPAA Privacy. The Company and the Group shall comply with the HIPAA privacy regulations as set forth in the benefit booklet, as amended from time to time, except to the extent superseded by the HIPAA privacy regulations themselves. Does the Group use a Third Party Administrator or consultant for any of its business functions related to this health plan (i.e., COBRA, eligibility, etc)? Yes Alliance Insurance Group

HIPAA Privacy. Consultant represents that in the performance of the Services pursuant to this Agreement, Consultant will fully comply with the requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the standards issued by the US Department of Health and Human Services at 45 C.F.R. Parts 160 and 164, to protect the security and privacy of individually identifiable health information generated by or received from Walgreens, if any, and if required by Walgreens, Consultant agrees to enter into a Business Associates Agreement with Walgreens in form and substance acceptable to Walgreens. Consultant will immediately provide written notice to the Office of Walgreens' Chief Privacy Officer at ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, MS# 9000, ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ if in the course of providing Services to Walgreens, Consultant has obtained or will obtain access to individually identifiable health information ("protected health information" or "PHI") as defined by HIPAA.

HIPAA Privacy. In spite of Sections 5(a) above, PS&F and City of Aspen will each comply with any prohibitions, restrictions, limitations, conditions, or other requirements to the extent they apply to them directly or indirectly pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and its implementing regulation concerning privacy of individually identifiable health information as set forth in 45 CFR Parts 160-164, as amended from time to time. As required under HIPAA, Client and PS&F will enter into a separate Business Associate Agreement.

HIPAA Privacy. Maintaining the confidentiality of medical information is of critical importance. Please review the Letter from the Department’s Executive Director, Office of Health Services (Refer to Section 1, Addendum). The letter provides details about patient privacy and the role of the Medicaid Program in assuring that services rendered to Medicaid recipients are delivered in accordance with the Maryland COMAR regulations.

HIPAA Privacy. Contemporaneously with the execution of this Agreement, the NHIC and TIC shall execute a Business Associate Addendum as attached as Exhibit B hereto and incorporated herein by this reference.

HIPAA Privacy. Contemporaneously with the execution of this Agreement, the JHUSA and TIC shall execute a Business Associate Addendum as attached as Exhibit C hereto and incorporated herein by this reference.

HIPAA Privacy. To Seller’s knowledge, except as provided on Schedule 2.21 or as set forth in a writing delivered by Seller to Purchaser on or prior to the Effective Date which specifically makes reference to Section 2.21, Seller is, and since January 1, 2016 has been, in material compliance with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, enacted as Title XIII of the American Recovery and Reinvestment Act of 2009, (“HIPAA”) and the implementing regulations thereunder governing the privacy of individually identifiable information and the security of such information, state law governing the privacy and security of health-related medical information or personal information, and any “business associate” agreement entered into by Seller. Seller and the Seller Businesses have at all times taken the necessary steps (including, without limitation, implementing reasonable and appropriate technical, physical and administrative safeguards, and monitoring compliance therewith) to (a) protect personally identifiable information, including protected health information (“PHI”) (as defined under HIPAA) (collectively, “Personally Identifiable Information”), against unauthorized access, use, transfer, modification, disclosure, misuse, destruction, loss, or anticipated threats or hazards, and (b) ensure the availability, integrity and confidentiality of any such PHI in compliance with applicable laws. To Seller’s knowledge, except as provided on Schedule 2.21, since January 1, 2016, Seller and the Seller Businesses have not suffered any actual breach, unauthorized disclosure or misuse of any Personally Identifiable Information and, to the knowledge of Seller, Seller and the Seller Businesses have not suffered any threatened breach, unauthorized disclosure or misuse of any Personally Identifiable Information. Except as set forth on Schedule 2.21, Seller and the Seller Businesses have not been the subject of any claim, proceeding or, to Seller’s knowledge, investigation relating to the actual breach, unauthorized disclosure or misuse of any Personally Identifiable Information and, to the knowledge of Seller, Seller and the Seller Businesses have not been the subject of any threatened claim, proceeding or investigation relating to the threatened breach, unauthorized disclosure or misuse of any Personally Identifiable Information.